We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PBH market cap is 4.14B. The company's latest EPS is USD 4.2372 and P/E is 19.71.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 279.31M | 286.32M | 282.74M | 276.99M | 267.14M |
| Operating Income | 85.19M | 88.25M | 86.83M | 82.15M | 72.05M |
| Net Income | 53.28M | 53.56M | 53.05M | 49.46M | 49.07M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 963.01M | 943.37M | 1.09B | 1.13B | 1.13B |
| Operating Income | 291.16M | 297.4M | 329.92M | -22.42M | 342.43M |
| Net Income | 142.28M | 164.68M | 205.38M | -82.31M | 209.34M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.35B | 3.33B | 3.34B | 3.32B | 3.31B |
| Total Liabilities | 1.87B | 1.8B | 1.74B | 1.66B | 1.63B |
| Total Equity | 1.48B | 1.54B | 1.6B | 1.66B | 1.68B |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.51B | 3.43B | 3.67B | 3.35B | 3.32B |
| Total Liabilities | 2.34B | 2.07B | 2.09B | 1.91B | 1.66B |
| Total Equity | 1.17B | 1.36B | 1.58B | 1.45B | 1.66B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 48.09M | 110.55M | 182.02M | 248.93M | 54.78M |
| Investing | 2.32M | -611k | -5.11M | -20.11M | -2.13M |
| Financing | -54.18M | -107.73M | -172.57M | -241.02M | -65.52M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 217.12M | 235.61M | 259.92M | 229.72M | 248.93M |
| Investing | -16.57M | -22.24M | -256.51M | -11.58M | -20.11M |
| Financing | -131.43M | -279.42M | -7.57M | -185.85M | -241.02M |
| Market Cap | 4.14B |
| Price to Earnings Ratio | 19.71 |
| Price to Sales Ratio | 3.67 |
| Price to Cash Ratio | 88.77 |
| Price to Book Ratio | 2.49 |
| Dividend Yield | - |
| Shares Outstanding | 49.41M |
| Average Volume (1 week) | 296.61k |
| Average Volume (1 Month) | 304.41k |
| 52 Week Change | 43.59% |
| 52 Week High | 84.21 |
| 52 Week Low | 56.61 |
| Spread (Intraday) | 0.14 (0.17%) |
| Company Name | Prestige Consumer Healthcare Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.prestigebrands.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
